Page last updated: 2024-10-30

leflunomide and Hypertrophy, Left Ventricular

leflunomide has been researched along with Hypertrophy, Left Ventricular in 2 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ma, ZG1
Zhang, X1
Yuan, YP1
Jin, YG1
Li, N1
Kong, CY1
Song, P1
Tang, QZ1
Daïen, CI1
Fesler, P1
du Cailar, G1
Daïen, V1
Mura, T1
Dupuy, AM1
Cristol, JP1
Ribstein, J1
Combe, B1
Morel, J1

Trials

1 trial available for leflunomide and Hypertrophy, Left Ventricular

ArticleYear
Etanercept normalises left ventricular mass in patients with rheumatoid arthritis.
    Annals of the rheumatic diseases, 2013, Volume: 72, Issue:6

    Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cohort Studies; Echocardiography; Etanerce

2013

Other Studies

1 other study available for leflunomide and Hypertrophy, Left Ventricular

ArticleYear
A77 1726 (leflunomide) blocks and reverses cardiac hypertrophy and fibrosis in mice.
    Clinical science (London, England : 1979), 2018, 03-30, Volume: 132, Issue:6

    Topics: Animals; Cell Differentiation; Cells, Cultured; Disease Models, Animal; Fibroblasts; Fibrosis; Heart

2018